Last reviewed · How we verify

Incretin analogues — Competitive Intelligence Brief

Incretin analogues (Incretin analogues) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Incretin mimetic (GLP-1 receptor agonist or GIP receptor agonist). Area: Diabetes.

marketed Incretin mimetic (GLP-1 receptor agonist or GIP receptor agonist) GLP-1R or GIPR Diabetes Small molecule Live · refreshed every 30 min

Target snapshot

Incretin analogues (Incretin analogues) — Khoo Teck Puat Hospital. Incretin analogues mimic the action of incretin hormones to stimulate insulin secretion in response to glucose intake, thereby lowering blood glucose levels in patients with type 2 diabetes.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Incretin analogues TARGET Incretin analogues Khoo Teck Puat Hospital marketed Incretin mimetic (GLP-1 receptor agonist or GIP receptor agonist) GLP-1R or GIPR

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Incretin mimetic (GLP-1 receptor agonist or GIP receptor agonist) class)

  1. Khoo Teck Puat Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Incretin analogues — Competitive Intelligence Brief. https://druglandscape.com/ci/incretin-analogues. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: